<DOC>
	<DOCNO>NCT00706784</DOCNO>
	<brief_summary>This research study look well new drug delivery system , call vaginal ring , work get hormone body form birth control .</brief_summary>
	<brief_title>Ethylvinyl Acetate ( EVA ) Vaginal Ring Delivery System Study</brief_title>
	<detailed_description>3-Day Study ( outpatient ) Healthy normal volunteer participate 3-day outpatient study begin day 1-7 menstrual cycle ( i.e . early follicular phase ) . A negative urinary hCG obtain woman prior start 3-day study . On first day , subject 4 baseline blood sample 5mL draw 20-minute interval hour ( Time = 0 , +20 , +40 , +60 ) . These pooled represent pretreatment determination gonadotropins sex steroid level . Thereafter , individual vaginal ring test inserted . Over ensue 3 day , subject 3 blood draw per day ( approximately 8-9 AM , 12-1PM , 4-5PM ) . Serum level LH , FSH , E2 , P determine time point next 3 day . A repeat CBC LFT 's do final blood draw . The exception protocol patient Sex Steroid Only ring 75 ug/kg GnRH antagonist ( Acyline IND # 58,448 ) administer subcutaneously every day upon subsequent onset menses , subject return day 3-6 repeat LFT 's gonadotropin . This ensure return normal liver function hormonal level . A visual vaginal examination colposcopy do baseline time removal ring . If lesion abrasion find study termination , subject follow lesion resolve . For initial 3-day study , daily visual inspection vaginal tissue conduct finding record standardized manner . The schedule intensive early sampling select certain rapid release medication occur ring early phase follow insertion . This also document , fact , achieve steady state release ring 's content circulation prior expand duration study 14 day second portion part A . 14 Day Study ( 14-Day Outpatient + 36-hour Inpatient ) Healthy normal volunteer participate 14-day study begin day 1-7 menstrual cycle ( i.e . early follicular phase ) . A negative urinary hCG obtain woman prior start 14-day study . On first day , subject 4 baseline blood sample 5mL draw 20-minute interval hour ( Time = 0 , +20 , +40 , +60 ) . These pooled represent pretreatment determination gonadotropins sex steroid level . The individual vaginal ring test inserted . Subjects return day next 13 day 8am 12pm General Clinical Research Center 5mL blood drawn measure serum level LH , FSH , E2 , P. On day 14 , vaginal ring remove . A visual vaginal examination colposcopy do baseline time removal ring . If lesion abrasion find study termination , subject follow lesion resolve . For initial 14-day study , visual inspection vaginal tissue conduct least 3 time per week finding record standardized manner . Two day later , subject admit General Clinical Research Center hour 8am 12pm 36-hour inpatient stay . Subjects give 240 ug dose GnRH agonist intravenously subject 's blood draw GnRHa determination 0 , 15 , 30 , 60 , 75 , 90 , 120min , hourly remain 36 hour . A repeat cbc draw final blood draw . These determination compare GnRH agonist determination vaginal route delivery previous 14 day hence % absorption GnRHa vagina . The exception protocol patient Sex Steroid Only ring 75 ug/kg GnRH antagonist ( Acyline IND # 58,448 ) administer subcutaneously every day course 14 day . These subject undergo inpatient stay ring remove . Repeat LFT 's drawn final blood draw well . Anytime Acyline injection give , subject monitor least 30 minute injection signs/symptoms allergic reaction . Upon subsequent onset menses , subject return day 3-6 repeat LFT 's gonadotropin . This ensure return normal liver function hormonal level .</detailed_description>
	<criteria>1 . A history normal regular menstrual cycle ( 2535 day ) ; 2 . A normal physical examination ; 3 . A body mass index ( BMI ) 19 &amp; 29 4 . A normal CBC , normal Prolactin level , normal LFT 's 5 . A negative urinary hCG initiation study ; 6 . An agreement refrain attempt conceive experimental cycle cycle thereafter either abstinence and/or use barrier method contraception .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Healthy woman 18-40 year age</keyword>
</DOC>